Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial.
Authors: Vaccaro, O; Masulli, M; Bonora, E; Del Prato, S; Giorda, CB; Maggioni, AP; Mocarelli, P; Nicolucci, A; Rivellese, AA; Squatrito, S; Riccardi, G; Giordano, C
